Side-by-Side Comparison · 2026

Klow vs OTR-AC

Klow vs OTR-AC — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

Klow
Healing & Recovery

Klow is a vendor peptide blend combining TB-500, BPC-157, KPV, and GHK-Cu - four compounds covering systemic tissue repair, angiogenesis, gut protection, anti-inflammation, and skin regeneration. It is the expanded version of Tri-Heal (TB-500 + BPC-157 + KPV), with GHK-Cu added f...

Calculate Klow dose →
OTR-AC
Healing & Recovery

OTR-AC is the common name for oral high-dose BPC-157 acetate. The peptide sequence (GEPPPGKPADDAGLV) is identical to injectable BPC-157 but is dosed at 2–5 mg orally rather than 250–500 µg subcutaneously to compensate for GI degradation and first-pass metabolism. The oral route p...

Calculate OTR-AC dose →
Key Parameters
Parameter Klow OTR-AC
Category Healing & Recovery Healing & Recovery
Research Vendor Blend Preclinical
Half-Life - 4–6 hours (estimated, oral)
Typical Dose - 2–5 mg
Frequency - Once daily
Route Subcutaneous Oral
FDA Status Not Approved Not Approved

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Frequently Asked Questions
What is the difference between Klow and OTR-AC?
Klow: Klow is a vendor peptide blend combining TB-500, BPC-157, KPV, and GHK-Cu - four compounds covering systemic tissue repair, angiogenesis, gut protection, anti-inflammation, and skin regeneration. It i... OTR-AC: OTR-AC is the common name for oral high-dose BPC-157 acetate. The peptide sequence (GEPPPGKPADDAGLV) is identical to injectable BPC-157 but is dosed at 2–5 mg orally rather than 250–500 µg subcutaneou...
Which has a longer half-life, Klow or OTR-AC?
Klow half-life: unknown. OTR-AC half-life: 4–6 hours (estimated, oral).
Can you stack Klow and OTR-AC?
Klow and OTR-AC are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.